8-K: Current report filing
Published on November 17, 2003
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON DC 20549
_____________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: November 17, 2003
ACCESS PHARMACEUTICALS, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-9314 83-0221517
- ---------------------------- ------------- ----------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
2600 Stemmons Frwy. Suite 176, Dallas, TX 75207
---------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (214) 905-5100
--------------
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
-------------------------------------------------------------------
(c) Exhibits.
---------
99.1 Access Pharmaceuticals, Inc. Press Release, dated November 14, 2003.
Item 12. Disclosure of Results of Operations and Financial Condition.
Access Pharmaceuticals, Inc. issued a press release on November 17, 2003,
a copy of which is attached as Exhibit 99.1 to this report and incorporated
herein by this reference, in which it announced that on November 17, 2003 it
will report its financial results for the third quarter ended September 30,
2003. It will have a conference call on November 17, 2003 to discuss the
results. This information shall not be deemed to be "filed" for the purposes
of Section 18 of the Securities Exchange Act of 1934 and shall not be
deemed to be incorporated by reference in any filing under the Securities
Act of 1933.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ACCESS PHARMACEUTICALS, INC.
Dated: November 17, 2003 By: /s/ Stephen B. Thompson
------------------------
Stephen B. Thompson
Vice President and
Chief Financial Officer
(Principal Financial and
Accounting Officer)
EXHIBIT INDEX
Exhibit Number Description
- -------------- ------------
99.1 Press Release, dated November 17, 2003